Locations:
Search
Infliximab-abda offers similar benefits at lower costs
More accurate than existing noninvasive tests
A cost-effective alternative to enoxaparin?
Results of the largest population-based study to date
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Rates similar for both methods
Multicenter observational study shows no simple answer
Measuring outcomes becomes more granular with surgeon-entered data
Challenging an old surgical standard
Study findings call for paradigm shift in standard of care
Multidisciplinary critical care in the time of COVID-19
Advertisement
Advertisement